FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116827889> ?p ?o ?g. }

• W2116827889 endingPage "490" @default.
• W2116827889 startingPage "484" @default.
• W2116827889 abstract "The APOE gene locus has 3 major alleles, E3, E4 and E2, which variably influence coronary heart disease (CHD) risk. Plasma low-density lipoprotein (LDL) profile, another major CHD risk factor, is characterized on the basis of size and density into 2 main patterns: large buoyant LDL and small dense LDL. The latter has also been linked with increased CHD risk. This study investigates associations of specific APOE allelic patterns with LDL size and subfraction profiles in patients with CHD and healthy control subjects. We recruited 2 groups of male subjects: (A) 65 apparently healthy control subjects, median age, 39.0 years (range, 25.0-60.0 years); (B) 50 patients with CHD, median age, 54.0 years (range, 40.0-76.0 years). APOE genotypes were determined by validated polymerase chain reaction-restriction fragment length polymorphism methods, and LDL size and subfractions were assessed by a high-resolution, nongradient polyacrylamide gel electrophoresis technique (LIPOPRINT, Quantimetrix, Redondo Beach, CA). Lipid and other biochemical analyses were done by autoanalyzer techniques. The associations of specific APOE alleles and genotypes with LDL size and subfraction patterns were then assessed. As expected, patients with CHD had a worse atherogenic lipoprotein profile (waist-hip ratio, LDL, uric acid, and apolipoprotein B) than the controls. APOE genotype and allele frequencies were similar for both groups. In either group, median percent large buoyant LDL (pattern A) was greater in controls (51.0% vs 46.5%, P < .001) and percent small dense LDL (pattern B) was greater with CHD (9.0% vs 3.0%, P < .001). The latter also had smaller median particle size (26.5 vs 26.9 nm, P < .001). In controls, percent LDL pattern B was significantly lower with APOE2 than with APO non-E2 (4.0% vs 0.0%, P < .05); in patients with CHD, E2 patients had smaller particle size, and pattern B was significantly lower with non-E2 than with E2 (15.0 vs 8.0, P < .05). With respect to E4, control non-E4 had a smaller median percent LDL pattern B than E4; otherwise, there were no significant findings in relation to APOE type and LDL size and subfractions in both subject groups. These results confirm observations in other populations of increased levels of small dense LDL in patients with CHD. Although the APOE allelic pattern, especially APOE2, could be related to LDL subfraction profiles in control subjects, such associations could not be demonstrated in those with CHD." @default.
• W2116827889 created "2016-06-24" @default.
• W2116827889 creator A5004078722 @default.
• W2116827889 creator A5055816055 @default.
• W2116827889 creator A5081893841 @default.
• W2116827889 creator A5087599269 @default.
• W2116827889 creator A5091602935 @default.
• W2116827889 date "2007-04-01" @default.
• W2116827889 modified "2023-10-05" @default.
• W2116827889 title "Associations of apolipoprotein E polymorphism with low-density lipoprotein size and subfraction profiles in Arab patients with coronary heart disease" @default.
• W2116827889 cites W1941151034 @default.
• W2116827889 cites W1961904860 @default.
• W2116827889 cites W1990739223 @default.
• W2116827889 cites W1998242338 @default.
• W2116827889 cites W2009013500 @default.
• W2116827889 cites W2026614584 @default.
• W2116827889 cites W2034968148 @default.
• W2116827889 cites W2035233054 @default.
• W2116827889 cites W2036362108 @default.
• W2116827889 cites W2036467420 @default.
• W2116827889 cites W2049959955 @default.
• W2116827889 cites W2052443991 @default.
• W2116827889 cites W2061357887 @default.
• W2116827889 cites W2075292143 @default.
• W2116827889 cites W2080831516 @default.
• W2116827889 cites W2092831846 @default.
• W2116827889 cites W2097573767 @default.
• W2116827889 cites W2101333957 @default.
• W2116827889 cites W2102786418 @default.
• W2116827889 cites W2111774300 @default.
• W2116827889 cites W2114063969 @default.
• W2116827889 cites W2116404316 @default.
• W2116827889 cites W2119535733 @default.
• W2116827889 cites W2122568730 @default.
• W2116827889 cites W2122952168 @default.
• W2116827889 cites W2127819032 @default.
• W2116827889 cites W2129883875 @default.
• W2116827889 cites W2131863370 @default.
• W2116827889 cites W2152086330 @default.
• W2116827889 cites W2155168556 @default.
• W2116827889 cites W2159581689 @default.
• W2116827889 cites W2160547740 @default.
• W2116827889 cites W2165539109 @default.
• W2116827889 cites W2167414527 @default.
• W2116827889 cites W2411977952 @default.
• W2116827889 cites W4242158045 @default.
• W2116827889 cites W2020977188 @default.
• W2116827889 doi "https://doi.org/10.1016/j.metabol.2006.11.006" @default.
• W2116827889 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17379005" @default.
• W2116827889 hasPublicationYear "2007" @default.
• W2116827889 type Work @default.
• W2116827889 sameAs 2116827889 @default.
• W2116827889 citedByCount "28" @default.
• W2116827889 countsByYear W21168278892012 @default.
• W2116827889 countsByYear W21168278892013 @default.
• W2116827889 countsByYear W21168278892014 @default.
• W2116827889 countsByYear W21168278892015 @default.
• W2116827889 countsByYear W21168278892016 @default.
• W2116827889 countsByYear W21168278892019 @default.
• W2116827889 countsByYear W21168278892021 @default.
• W2116827889 countsByYear W21168278892022 @default.
• W2116827889 crossrefType "journal-article" @default.
• W2116827889 hasAuthorship W2116827889A5004078722 @default.
• W2116827889 hasAuthorship W2116827889A5055816055 @default.
• W2116827889 hasAuthorship W2116827889A5081893841 @default.
• W2116827889 hasAuthorship W2116827889A5087599269 @default.
• W2116827889 hasAuthorship W2116827889A5091602935 @default.
• W2116827889 hasConcept C104317684 @default.
• W2116827889 hasConcept C126322002 @default.
• W2116827889 hasConcept C134018914 @default.
• W2116827889 hasConcept C135763542 @default.
• W2116827889 hasConcept C168007829 @default.
• W2116827889 hasConcept C180754005 @default.
• W2116827889 hasConcept C2778163477 @default.
• W2116827889 hasConcept C2778913445 @default.
• W2116827889 hasConcept C2779134260 @default.
• W2116827889 hasConcept C2779620165 @default.
• W2116827889 hasConcept C2780072125 @default.
• W2116827889 hasConcept C3018906752 @default.
• W2116827889 hasConcept C54355233 @default.
• W2116827889 hasConcept C57089818 @default.
• W2116827889 hasConcept C62746215 @default.
• W2116827889 hasConcept C71924100 @default.
• W2116827889 hasConcept C86803240 @default.
• W2116827889 hasConcept C90924648 @default.
• W2116827889 hasConceptScore W2116827889C104317684 @default.
• W2116827889 hasConceptScore W2116827889C126322002 @default.
• W2116827889 hasConceptScore W2116827889C134018914 @default.
• W2116827889 hasConceptScore W2116827889C135763542 @default.
• W2116827889 hasConceptScore W2116827889C168007829 @default.
• W2116827889 hasConceptScore W2116827889C180754005 @default.
• W2116827889 hasConceptScore W2116827889C2778163477 @default.
• W2116827889 hasConceptScore W2116827889C2778913445 @default.
• W2116827889 hasConceptScore W2116827889C2779134260 @default.
• W2116827889 hasConceptScore W2116827889C2779620165 @default.
• W2116827889 hasConceptScore W2116827889C2780072125 @default.
• W2116827889 hasConceptScore W2116827889C3018906752 @default.
• W2116827889 hasConceptScore W2116827889C54355233 @default.

• next